Bioavailability and bioequivalence of two enteric-coated formulations of omeprazole in fasting and fed conditions.
about
Drug-drug interactions between sucroferric oxyhydroxide and losartan, furosemide, omeprazole, digoxin and warfarin in healthy subjects.The value of branded proton pump inhibitors: formulary considerations.Pharmacokinetics of rabeprazole granules versus tablets, and the effect of food on the pharmacokinetics of rabeprazole granules in healthy adults-cross-study comparison.
P2860
Bioavailability and bioequivalence of two enteric-coated formulations of omeprazole in fasting and fed conditions.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Bioavailability and bioequival ...... in fasting and fed conditions.
@ast
Bioavailability and bioequival ...... in fasting and fed conditions.
@en
Bioavailability and bioequival ...... in fasting and fed conditions.
@nl
type
label
Bioavailability and bioequival ...... in fasting and fed conditions.
@ast
Bioavailability and bioequival ...... in fasting and fed conditions.
@en
Bioavailability and bioequival ...... in fasting and fed conditions.
@nl
prefLabel
Bioavailability and bioequival ...... in fasting and fed conditions.
@ast
Bioavailability and bioequival ...... in fasting and fed conditions.
@en
Bioavailability and bioequival ...... in fasting and fed conditions.
@nl
P2093
P50
P1476
Bioavailability and bioequival ...... in fasting and fed conditions
@en
P2093
Ana I Loureiro
Joana Maia
Manuel Vaz-da-Silva
Pedro Silveira
Susana Tavares
Teresa Nunes
P304
P356
10.2165/00044011-200525060-00004
P577
2005-01-01T00:00:00Z